Recent updates on JAK inhibitors in the management of Rheumatoid Arthritis

Introduction

Take This Event

This webinar will include information on recent updates on JAK inhibitors in the management of Rheumatoid Arthritis to inform rheumatologists. European topic expert speakers will present recently disclosed data on various agents and real world evidence studies.

Objectives

Goals of this webinar are to provide information to rheumatologists on approved JAK inhibitors in the management of Rheumatoid Arthritis and to share efficacy, safety and pain mechanisms related data. Learning objectives are to understand pain mechanisms and role of JAK-STAT pathway on these mechanisms and to have an overall understanding on efficacy and safety profile of approved JAK inhibitors.

See Registration Policies, Cancellations & Refunds